Evidence map›Paper›PMID 26721734›Full record

ArticleBone2016

Osteogenic potential of alpha smooth muscle actin expressing muscle resident progenitor cells.

Brya G Matthews, Elena Torreggiani, Emilie Roeder, Igor Matic, Danka Grcevic, Ivo Kalajzic

Abstract read
In one paragraph

Article in Bone, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Extracellular Vesicles Secreted by TGF-Stem cells international · 2023
    Article
  9. Review
  10. Effect ofFrontiers in endocrinology · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Modulation of Notch1 signaling regulates bone fracture healing.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2020
    Article
  17. Single-Cell RNA Sequencing of Calvarial and Long-Bone Endocortical Cells.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2020
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Brya G MatthewsDepartment of Reconstructive Sciences, University of Connecticut Health Center, Farmington, CT, USA.
Elena TorreggianiDepartment of Reconstructive Sciences, University of Connecticut Health Center, Farmington, CT, USA.
Emilie RoederDepartment of Reconstructive Sciences, University of Connecticut Health Center, Farmington, CT, USA.
Igor MaticDepartment of Reconstructive Sciences, University of Connecticut Health Center, Farmington, CT, USA.
Danka GrcevicDepartment of Physiology and Immunology, School of Medicine, University of Zagreb, Zagreb, Croatia.
Ivo KalajzicDepartment of Reconstructive Sciences, University of Connecticut Health Center, Farmington, CT, USA. Electronic address: ikalaj@uchc.edu.

Funding

Notch Signaling and Bone Fracture HealingR01AR055607 · NIAMS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI Kurt David Hankenson, IVO Kalajzic · 2011 to 2026
$6.3M
NIAMS NIH HHS AR055607NIAMS NIH HHS R01 AR055607
6 · The paper itself

Abstract

Heterotopic ossification (HO) is a pathological process where bone forms in connective tissues such as skeletal muscle. Previous studies have suggested that muscle-resident non-myogenic mesenchymal progenitors are the likely source of osteoblasts and chondrocytes in HO. However, the previously identified markers of muscle-resident osteoprogenitors label up to half the osteoblasts within heterotopic lesions, suggesting other cell populations are involved. We have identified alpha smooth muscle actin (αSMA) as a marker of osteoprogenitor cells in bone and periodontium, and of osteo-chondro progenitors in the periosteum during fracture healing. We therefore utilized a lineage tracing approach to evaluate whether αSMACreERT2 identifies osteoprogenitors in the muscle. We show that in the muscle, αSMACreERT2 labels both perivascular cells, and satellite cells. αSMACre-labeled cells undergo osteogenic differentiation in vitro and form osteoblasts and chondrocytes in BMP2-induced HO in vivo. In contrast, Pax7CreERT2-labeled muscle satellite cells were restricted to myogenic differentiation in vitro, and rarely contributed to HO in vivo. Our data indicate that αSMACreERT2 labels a large proportion of osteoprogenitors in skeletal muscle, and therefore represents another marker of muscle-resident cells with osteogenic potential under HO-inducing stimulus. In contrast, muscle satellite cells make minimal contribution to bone formation in vivo.

Indexed as

OsteogenesisActinsAnimalsBiomarkersCell DifferentiationCell LineageCell MembraneCell SeparationFlow CytometryMiceMuscle, SkeletalOssification, HeterotopicPAX7 Transcription FactorSatellite Cells, Skeletal MuscleStem CellsActinsalpha-smooth muscle actin, mouseBiomarkersPax7 protein, mousePAX7 Transcription FactorAlpha smooth muscle actinHeterotopic ossificationMesenchymal progenitorOsteogenesisSatellite cell

Identifiers

PMID26721734
PMCPMC4755912

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.